+91-8668442535

In-Vitro Diagnostics Quality Control Market By Product (Quality Controls, Data Management Solutions, Quality Assurance Services), By Application (Immunochemistry, Clinical Chemistry, Hematology, Coagulation, Molecular Diagnostics, Microbiology, Others) - Growth, Future Prospects, Competitive Analysis, 2018 - 2026

The global in-vitro diagnostics quality control market was worth US$ 854.0 Mn in 2017 and is expected to expand at a compound annual growth rate (CAGR) of 3.9% from 2018 to 2026. In-vitro diagnostics quality control tests are performed to validate the efficacy and reliability of the in-vitro diagnostic systems, ensure their accuracy, and evaluate the impact of environmental conditions and other things that can affect the test results.

Erroneous in vitro diagnostic testing systems have significant side effects on patients. Moreover, it can delay diagnosis and may also result in improper treatment, leading to long-term complications and additional healthcare costs. Moreover, failure to identify the pathogen, especially during an outbreak, can delay determining the true cause and thereby lead to inaccurate measures for the same.

Poor diagnostic quality also leads to poor patient outcomes, increased mortality, and morbidity, posing a barrier to public health interventions. The growing usage of in-vitro diagnostic testing for various diseases, such as infectious diseases, cardiovascular disorders, and oncology testing, is the major driver for the growth of the in-vitro diagnostics quality control market. Moreover, a growing inclination towards personalized medicine and molecular diagnostics to explore knowledge and treatment for rare diseases is boosting the use of in vitro diagnostics, thereby growing the market for in vitro diagnostic quality control.

Market Synopsis

The quality controls segment accounted for the largest share by product type.

The in-vitro diagnostics quality control market is segmented into three categories: quality controls, data management solutions, and quality assurance services. In 2017, the quality control segment held the largest share of the market owing to the high demand for these products for validating the accuracy and precision of the in vitro diagnostic tests.

Quality control is an important aspect of clinical and laboratory-based testing to ensure safety and accuracy as per standards set by the Food and Drug Administration (FDA), the European Communities Confederation of Clinical Chemistry and Laboratory Medicine (EC4), and the Clinical Laboratory Improvement Amendments (CLIA).

Periods of History and Forecast

This research report presents the analysis of each segment from 2016 to 2026, considering 2017 as the base year for the research. The compound annual growth rate (CAGR) for each of the respective segments was calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The in-vitro diagnostics quality control market report furnishes quantitative analysis along with its latest market trends. The market is segmented based on product type, application, and geography.

The in-vitro diagnostics quality control market is studied to understand the current and future trends and dynamics. The study scope includes market size and forecasts for all considered segments studied in the report for the period from 2016 to 2026, along with a compound annual growth rate (CAGR) for the forecast period from 2018 to 2026, with 2017 being considered the base year.

The key players currently engaged in the in vitro diagnostics quality control market include Siemens Healthcare, Thermo Fisher Scientific, Inc., Roche Diagnostics, Bio-Rad Laboratories, Inc., Abbott Laboratories, Inc., Seracare Life Sciences, Inc., Sysmex Corporation, Helena Laboratories, and Sun Diagnostics, LLC, among others.

Key questions are answered in this report.

  • How will the global in-vitro diagnostics quality control market perform during the forecast period from 2018 to 2026?
  • What are the most recent trends in the in-vitro diagnostics quality control market, as well as the most promising opportunities for key players?
  • Who are the leading players in the global in-vitro diagnostics quality control market?
  • Which region leads and grows the most in the global in-vitro diagnostics quality control market?
  • What are the drivers and restraints governing the global in-vitro diagnostics quality control market?

Frequently Asked Question:

The market for In-Vitro Diagnostics Quality Control Market is expected to reach USD$ 854.0 Mn in 2026.

The In-Vitro Diagnostics Quality Control Market is expected to see significant CAGR growth over the coming years, at 3.9% .

The report is forecasted from 2018 -2026.

The base year of this report is 2017.

Thermo Fisher Scientific, Inc., Roche Diagnostics, Bio-Rad Laboratories, Inc., Abbott Laboratories, Inc., Seracare Life Sciences, Inc. are some of the major players in the global market.

Choose License Type
Trusted By
Godaddy
Published Date:  Mar 2019
Category:  Medical Devices
Report ID:   59637
Report Format:   PDF
Pages:   120
Rating:    4.2 (66)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support